From the Keeneland Media Crew:
Important North American Sales Companies Even further Align on Medicine Procedures for Thoroughbred Auctions
New guidelines improve equine safety and buyer confidence in the auction method
Officials from Keeneland Affiliation, Fasig-Tipton Firm Inc., and Ocala Breeders’ Sales Enterprise Inc. (OBS) right now jointly declared increased medication policies developed to safeguard the welfare of the horse even though generating better clarity and consistency amongst the nation’s 3 big U.S. Thoroughbred auction properties. The revised Situations of Sale will choose effect July 1, 2024.
These proactive steps are the end result of ongoing discussions concerning officers of the a few profits organizations, started past Oct at the invitation of the Horseracing Integrity and Security Authority (HISA), who attended the initial conference.
The aim of the new insurance policies is to additional improve equine basic safety, buyer self confidence and the reliability of the auction method. This is the fourth collaborative treatment reform motion taken by the 3 income providers since 2009.
The new procedures enhance current medicine guidelines, minimizing the selection of permitted therapeutic drugs while rising the number of prohibited prescription drugs to incorporate all substances at this time banned underneath HISA’s Anti-Doping and Medicine Control method. The penalties for violation of policies will also be greater.
Keeneland President and CEO Shannon Arvin, Fasig-Tipton President Boyd T. Browning Jr. and OBS President Tom Ventura stated in a joint assertion:
“We continue to refine our policies with the targets of guarding the well-remaining of the horse and supplying our customers with transparency and the very best chance for achievements at the race track. Horse basic safety and welfare will have to be a collaborative work throughout our activity, which incorporates the profits ring. We take our management roles toward that mission critically and remain united in our advocacy to provide the greatest fascination of the horse.”
Officials of Keeneland, Fasig-Tipton and OBS will keep on to evaluate these guidelines often and revise them, as essential, in coordination with one particular a further to boost consistency across the big U.S. Thoroughbred auctions. All income corporations will carry on to teach their contributors in the months foremost up to their respective sale dates.
Medication REFORM HIGHLIGHTS
The pursuing are amid the well known improvements to Disorders of Sale governing long run auctions at Keeneland, Fasig-Tipton and OBS, beginning July 1, 2024:
Non-steroidal anti-inflammatory medication (NSAIDs)
- No NSAID may well be administered to a horse within just 48 hours of an beneath-tack functionality.
- No NSAID may perhaps be administered to a horse after 6 p.m. the day prior to sale.
- NSAIDs permitted for use on the revenue grounds are Phenylbutazone (Bute), Flunixin Meglumine (Banamine) and Ketoprofen (Ketofen), at or under manufacturer’s suggested dosage (MRD). Only 1 these types of NSAID can be administered at any a person time (stacking is prohibited).
Corticosteroids
- No corticosteroid may perhaps be administered to a horse within just 48 hours of an underneath-tack overall performance.
- No corticosteroid could be administered to a horse within just 24 several hours of the start off of the session in which that horse is scheduled to offer.
Constrained exceptions to these guidelines may well be accommodated when recommended for a unique veterinary prognosis.